Regarding adiponectin, recent studies and meta-analyses have shown that lower plasma adiponectin levels are significantly associated with the presence and severity of NAFLD, suggesting hypoadiponectinemia as a potential risk factor for NAFLD [182,183,184]. This evidence concerns the gene ADIPOQ and metabolic dysfunction-associated steatotic liver disease.